Research study Program year 2024 Source: CMS Open Payments

Phase III Adjuvant Melanoma Monotherapy

Research payments

$3,095,512

177 payments

Through program year 2024, $3,095,512 in research payments was reported against Phase III Adjuvant Melanoma Monotherapy, across 177 payments, paid by E.R. Squibb & Sons, L.L.C..

Paid by
E.R. Squibb & Sons, L.L.C.
ClinicalTrials.gov
No trial number was reported for this study

By program year

6 rows
Year Kind Amount Payments
2024 Research $119,373 23
2023 Research $103,502 23
2022 Research $18,926 11
2021 Research $556,800 36
2020 Research $1,497,681 41
2019 Research $799,230 43

Breakdown

Who paid Research payments · program years 2019–2024
  1. E.R. Squibb & Sons, L.L.C. $3,095,512 177 payments
Who received the money Research payments · program years 2019–2024
  1. Ohsu Hospital And Clinics Teaching hospital · OR $480,397 5 payments
  2. Carolinas Medical Center Teaching hospital · NC $336,530 3 payments
  3. Wesley Woods Center Of Emory Univers Teaching hospital · GA $278,998 1 payment
  4. Uams Medical Center Teaching hospital · AR $164,348 5 payments
  5. Sarah Cannon Research Institute Organisation paid for research $147,146 4 payments
  6. Texas Oncology, P A Organisation paid for research $133,352 3 payments
  7. Duke University Institutional Review Board Organisation paid for research $105,681 2 payments
  8. Mount Sinai Medical Center Of Florid Teaching hospital · FL $90,111 3 payments
  9. Georgetown University Organisation paid for research $90,005 3 payments
  10. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $83,175 6 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record